PA
WOR icon

PharVision Advisers’s Worthington Enterprises WOR Stock Holding History

PharVision Advisers’s Portfolio WOR Stock Details WOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-5,753
Closed -$319K – 1035
2025
Q3 		$319K Buy
5,753
+1,341
+30% +$84.5K 0.18% 191
2025
Q2 		$281K Buy
+4,412
New +$244K 0.4% 93

Other funds holding WOR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

PharVision Advisers's WOR Position: Q4 2025 in Review

PharVision Advisers sold out of Worthington Enterprises (WOR) in Q4 2025, closing a stake of 5,753 shares — an estimated $319K sold.

PharVision Advisers first reported a position in WOR in Q2 2025 and held it in 2 quarters. The position peaked at $319K in Q3 2025. 285 funds tracked by Wall St. Rank hold WOR as of Q4 2025.

  • PharVision Advisers reported no remaining Worthington Enterprises position as of Q4 2025 after selling out during the quarter.
  • PharVision Advisers sold 5,753 Worthington Enterprises shares in Q4 2025, an estimated $319K.
  • PharVision Advisers first reported a position in Worthington Enterprises in Q2 2025 and held it in 2 quarters.
  • PharVision Advisers's Worthington Enterprises position peaked at $319K in Q3 2025.
  • 285 funds tracked by Wall St. Rank held Worthington Enterprises as of Q4 2025.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.